TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Ferring Pharmaceuticals A/S
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
226,581
|
195,563
|
169,632 |
| Earnings before taxes |
13,267
|
11,571
|
8,599 |
| Total assets |
74,328
|
78,681
|
65,311 |
| Current assets |
42,640
|
44,085
|
28,981 |
| Current liabilities |
37,866
|
42,375
|
34,401 |
| Equity capital |
35,686
|
25,403
|
16,405 |
| - share capital |
67
|
67
|
67 |
| Employees (average) |
750
|
350
|
350 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
48.0%
|
32.3%
|
25.1% |
| Turnover per employee |
302
|
559
|
485 |
| Profit as a percentage of turnover |
5.9%
|
5.9%
|
5.1% |
| Return on assets (ROA) | |||
| Current ratio |
112.6%
|
104.0%
|
84.2% |
| Return on equity (ROE) |
37.2%
|
45.5%
|
52.4% |
| Change turnover |
31,204
|
26,309
|
34,421 |
| Change turnover % |
16%
|
16%
|
25% |
| Chg. No. of employees |
400
|
0
|
0 |
| Chg. No. of employees % |
114%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.